Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - Cellular Biomedicine Group, Inc. | cbmg_10k.htm |
| EX-32 - CERTIFICATION - Cellular Biomedicine Group, Inc. | cbmg_ex32.htm |
| EX-31 - CERTIFICATION - Cellular Biomedicine Group, Inc. | cbmg_ex31.htm |
| EX-21 - SUBSIDIARIES - Cellular Biomedicine Group, Inc. | cbmg_ex21.htm |
| EX-23.1 - CONSENT - Cellular Biomedicine Group, Inc. | cbmg_ex231.htm |
| EX-10.39 - CONSULTING AGREEMENT - Cellular Biomedicine Group, Inc. | cbmg_ex1039.htm |
| EX-10.46 - CLINICAL TRIAL AGREEMENT - Cellular Biomedicine Group, Inc. | cbmg_ex1046.htm |
| EX-10.45 - PATENT TRANSFER AGREEMENT - Cellular Biomedicine Group, Inc. | cbmg_ex1045.htm |
| EX-10.43 - TECHNOLOGY TRANSFER CONTRACT - Cellular Biomedicine Group, Inc. | cbmg_ex1043.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Cellular Biomedicine Group, Inc.
19925 Stevens Creek Blvd., Suite 100
Cupertino, California 95014
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-198692, 333-187799, and 333-158583) of Cellular Biomedicine Group, Inc. and its subsidiaries and variable interest entities (the “Company”) of our reports dated March 11, 2016, relating to the Company’s consolidated financial statements and the effectiveness of the Company’s internal control over financial reporting, which appear in this Annual Report on Form 10-K for the year ended December 31, 2015.
/s/ BDO China Shu Lun Pan Certified Public Accountants LLP
BDO China Shu Lun Pan Certified Public Accountants LLP
Shenzhen, The People’s Republic of China
March 11, 2016